4 Recruiting Studies Using Danicopan
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Danicopan
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Assess Long-Term Safety of Danicopan Add-on Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria: Analysis of IPIG-Registry Data
📍 Clinical Research Site — Boston, Massachusetts
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Long-term Safety of Danicopan: IPIG Registry-based Cohort Study
📍 Alexion Pharmaceuticals, Inc. (Sponsor) — Boston, Massachusetts
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH
📍 Research Site — Los Angeles, California
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis
📍 Research Site — Saskatoon, Saskatchewan
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔